Amanda Boudreaux v. Abbvie, Inc.
Opinion
Trial Court Opinion
I. Background
Plaintiff Amanda Boudreaux received a bilateral wedge mastopexy in which Defendants Allergan, Inc., Allergan USA, Inc., AbbVie, Inc., and Sofregen Medical Inc.’s (collectively, “Defendants”) SERI Surgical Scaffold Mesh was used. Mot. at 1. She Case 8:22-cv-00424-DOC-ADS Document Filed 06/10/ Page 2 of Page ID #:977
UNITED STATES DISTRICT COURT
CENTRAL DISTRICT OF CALIFORNIA
CIVIL MINUTES – GENERAL
Case No. SA CV 22-00424-DOC-ADS Date: June 10, 22 Page
suffered injuries that she alleges were the result of the product’s design defect, Defendants’ failure to warn, and negligence. Id. at 3.
Plaintiffs filed suit in Orange County Superior Court on February 4, 2022. On March 17, 2022, Defendants removed the action to this Court. Id.
Plaintiffs are citizens of California. Id. They assert that Defendant Allergan, Inc. is also a citizen of California, where the action was filed. Id. at 1. Allergan, Inc. asserts in its notice of removal (“Not. of Removal”) (Dkt. 1) that for diversity jurisdiction purposes, its principal place of business is not in California, but in Illinois. Not. of Removal ¶ 15.